EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC 4.0

Intrapartum azithromycin to prevent maternal and neonatal sepsis and deaths: A systematic review with meta‐analysis

Ilari Kuitunen iD, Maiju Kekki iD, Marjo Renko

BJOG: An International Journal of Obstetrics & Gynaecology · 2024

DOI: 10.1111/1471-0528.17655 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, 2024. Verfasst von Ilari Kuitunen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland. Hauptthemen laut MEDLINE: Azithromycin, Neonatal Sepsis, Pregnancy Complications, Infectious, Sepsis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

A systematic review with met‐analysis was performed to summarise the evidence on the effect of intrapartum azithromycin on maternal and neonatal infections and deaths. Search strategy PubMed, Scopus and Web of Science databases were searched in March 2023. Selection criteria Randomised controlled trials comparing intrapartum single‐dose of azithromycin with placebo. Data collection and analysis Maternal infections, maternal mortality, neonatal sepsis, neonatal mortality. We used the random‐effects Mantel–Haenszel method to calculate risk ratios (RR) with 95% confidence intervals (95% CI). We assessed risk of bias of the included studies and estimated the evidence certainty using the GRADE approach. Main results After screening 410 abstracts, five studies with 44 190 women and 44 565 neonates were included. The risk of bias was low in four and had some concerns in one of the studies. The risk of endometritis was 1.5% in the azithromycin group and 2.3% in the placebo group (RR 0.64, 95% CI 0.55–0.75), and the evidence certainty was high. The respective risk for chorioamnionitis was 0.05% and 0.1% (RR 0.50, 95% CI 0.22–1.18; evidence certainty moderate). The wound infection rate was lower in the azithromycin group (1.6%) than in the placebo group (2.5%), RR 0.52 (95% CI 0.30–0.89; moderate certainty evidence). The maternal sepsis rate was 1.1% in the azithromycin group and 1.7% in the placebo group (RR 0.66, 95% CI 0.56–0.77; evidence certainty high). Mortality rates did not show evidence of a difference (0.09% versus 0.08%; RR 1.26, 95% CI 0.65–2.42; moderate certainty evidence). The neonatal mortality rate was 0.7% in the azithromycin group and 0.8% in the placebo group (RR 0.94, 95% CI 0.76–1.16; moderate certainty evidence). The neonatal sepsis rate was 7.6% in the azithromycin group and 7.4% in the placebo group (RR 1.02, 95% CI 0.96–1.09; moderate certainty evidence).

Conclusions

Intrapartum administration of azithromycin to the mother reduces maternal postpartum infections, including sepsis. Impact on maternal mortality remains undecided. Azithromycin does not reduce neonatal sepsis or mortality rates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AzithromycinNeonatal SepsisPregnancy Complications, InfectiousSepsisPeripartum PeriodFemaleHumansInfant, NewbornPregnancyChorioamnionitisRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

azithromycinmeta-analysismortalityperinatal outcomessepsis

Substanzen

Azithromycin

Autor:innen und Institutionen

  • Department of Paediatrics, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
  • Department of Paediatrics, Kuopio University Hospital, Kuopio, Finland.
  • Department of Obstetrics, Tampere University Hospital, Tampere, Finland.
  • Tampere Centre for Child and Maternal Health Research, Tampere University, Tampere, Finland.

ORCID-Profile: Ilari Kuitunen, Maiju Kekki

Zitieren

APA

Kuitunen, I., Kekki, M., & Renko, M. (2024). Intrapartum azithromycin to prevent maternal and neonatal sepsis and deaths: A systematic review with meta‐analysis. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.17655

Vancouver

Kuitunen I, Kekki M, Renko M. Intrapartum azithromycin to prevent maternal and neonatal sepsis and deaths: A systematic review with meta‐analysis. BJOG: An International Journal of Obstetrics & Gynaecology. 2024. doi:10.1111/1471-0528.17655

BibTeX
@article{Kuitunen2024,
  author = {Kuitunen, Ilari and Kekki, Maiju and Renko, Marjo},
  title = {Intrapartum azithromycin to prevent maternal and neonatal sepsis and deaths: A systematic review with meta‐analysis},
  journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
  year = {2024},
  doi = {10.1111/1471-0528.17655}
}
Kostenlos starten →